Skip to main content

Advertisement

SpringerLink
Log in

Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Background. Incidence patterns are well-established for invasive breast carcinoma (InvBC) overall and for InvBC defined by estrogen receptor (ER) expression, but are not as well-defined for breast carcinoma in situ (CIS). Methods. We, therefore, examined and compared the incidence patterns for CIS and InvBC in the SEER program to define these patterns and to generate etiologic hypotheses. Data were stratified by age <50 and ≥50 years to approximate menopause. Results. During the years 1973–2000, annual age-adjusted incidence rates rose 660% for CIS and 36% for InvBC, with the most rapid increases occurring in women age ≥50 years. Age-specific incidence rate curves for CIS increased until age 50 years, and then flattened, irrespective of ER expression. On the other hand, rates for InvBC overall and for InvBC defined by ER-positive expression increased continuously with aging, whereas rates for InvBC defined by ER-negative expression flattened after 50 years. Age frequency distribution for CIS and for ER-negative InvBC demonstrated bimodal populations, with a predominant early onset peak incidence at age 50 years. Age frequency distribution for ER-positive InvBC showed bimodal populations with a predominant late-onset mode at age 71 years. Conclusion. Over the last three decades, age-adjusted incidence trends differed for CIS and InvBC in the United States, possibly due to screening mammography and/or etiologic diversity. Indeed, age-specific incidence patterns suggested that carcinogenic events operating early in reproductive life had greater impact upon CIS and InvBC defined by ER-negative expression than upon InvBC overall and InvBC defined by ER-positive expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Anderson WF, Chu KC, Chatterjee N, Brawley OW, Brinton LA:Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the surveillance,epidemiology,and end results database. J Clin Oncol 19:18–27, 2001

    Google Scholar 

  2. Tarone RE, Chu KC: The greater impact of menopause on ER-than ER+breast cancer incidence:a possible explanation (United States). Cancer Causes Control 13:7–14, 2002

    Google Scholar 

  3. Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW: Frequency distributions of breast cancer characteristics classied by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92:37–45, 2001

    Google Scholar 

  4. Chu KC, Anderson WF:Rates for breast cancer charac-teristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat 74: 199–211, 2002

    Google Scholar 

  5. Anderson WF, Chatterjee N, Ershler WB, Brawley OW: Estrogen receptor breast cancer phenotypes in the surveil-lance, epidemiology, and end results database. Breast Cancer Res Treat 76: 27–36, 2002

    Google Scholar 

  6. Anderson WF, Chu KC, Chang S: In flammatory breast carcinoma and non-inflammatory locally advanced breast carcinoma:distinct clinicopathologic entities? J Clin Oncol 21:2254–2259, 2003

    Google Scholar 

  7. Anderson WF, Chu KC, Chang S:In flammatory breast carcinoma: the sphinx of breast cancer research (in Reply). J Clin Oncol 22: 381–384, 2004 (letter)

    Google Scholar 

  8. Anderson WF, Chu KC, Chang S, Sherman ME:Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Cancer Epidemiol Biomarkers Prev 13: 1–8, 2004

    Google Scholar 

  9. Anderson WF, Althuis MD, Brinton LA, Devesa SS: Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 83: 77–86, 2004

    Google Scholar 

  10. Clemmesen J:Carcinoma of the breast. Br J Radiol 21: 583–590, 1948

    Google Scholar 

  11. Yasui Y, Potter JD: The shape of age-incidence curves of female breast cancer by hormone-receptor status. Cancer Causes Control 10:431–437, 1999

    Google Scholar 

  12. SEER:Surveillance, Epidemiology, and End Results (SEER) Program. Public-Use Data (1973–2000), National Cancer Institute, DCCPS, Surveillence Research Program, Cancer Statistics Branch, released 2003, based on the November 2002 submission, 2003, www.seer. cancer.gov

  13. Percy C, Holten VV, Muir C:International Classi cation of Diseases for Oncology, World Health Organization:Geneva 1990

  14. Armitage P, Doll R: The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 8:1–12, 1954

    Google Scholar 

  15. Van de Vijver MJ, Peterse H:The diagnosis and manage-ment of pre-invasive breast disease:pathological diagnosis–problems with existing classi cations. Breast Cancer Res 5: 269–275,2003

    Google Scholar 

  16. Allred DC, Mohsin SK, Fuqua SA:Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8:47–61, 2001

    Google Scholar 

  17. Azzopardi JG:Benign and malignant proliferative epithelial lesions of the breast:a review. Eur J Cancer Clin Oncol 19: 1717–1720, 1983

    Google Scholar 

  18. Iglehart JD, Kerns BJ, Huper G, Marks JR:Maintenance of DNA content and erbB-2 alterations in intraductal and invasive phases of mammary cancer. Breast Cancer Res Treat 34:253–263, 1995

    Google Scholar 

  19. Devesa SS: Descriptive epidemiology of cancer of the uterine cervix. Obstet Gynecol 63:605–612, 1984

    Google Scholar 

  20. Winawer SJ: A quarter century of colorectal cancer screening:progress and prospects. J Clin Oncol 19:6S-12S, 2001

    Google Scholar 

  21. Rous P, Beard JW: The progression to carcinoma of virus-induced rabbit papillomas (Shope). J Exp Med 62:523–548e, 1935

    Google Scholar 

  22. Claus EB, Stowe M, Carter D:Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst 93: 1811–1817,2001

    Google Scholar 

  23. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC:Progress in cancer screening practices in the United States:results from the 2000 National Health Interview Survey. Cancer 97:1528–1540, 2003

    Google Scholar 

  24. Ottesen GL:Carcinoma in situ of the female breast. A clinico-pathological, immunohistological,and DNA ploidy study. APMIS Suppl:1–67, 2003

  25. Ries LAG, Eisner MP, Kosary CL, Hankey BF, Miller BA, Clegg L,Edwards BK:SEER Cancer Statistics Review, 1975–2000, 2003, http://seer.cancer.gov/csr/1975 2000/ sections.html

  26. Rosen PP, Braun DW, Jr, Kinne DE: The clinical signicance of pre-invasive breast carcinoma.Cancer 46:919–925, 1980

    Google Scholar 

  27. Page DL, Dupont WD, Rogers LW, Landenberger M: Intraductal carcinoma of the breast:follow-up after biopsy only.Cancer 49:751–758, 1982

    Google Scholar 

  28. Page DL, Dupont WD, Rogers LW, Jensen RA, Schuyler PA:Continued local recurrence of carcinoma 15–25 years after a diagnosis of low grade ductal carcinoma in situ of the breast treated only by biopsy.Cancer 76:1197–1200,1995

    Google Scholar 

  29. Kinne DW, Petrek JA, Osborne MP, Fracchia AA, DePalo AA, Rosen PP: Breast carcinoma in situ.Arch Surg 124: 33–36,1989

    Google Scholar 

  30. Morrow M, Schnitt SJ, Harris JR: Ductal carcinoma in situ and microinvasive carcinoma. In: Jay R.Harris, Marc E. Lippman, Monica Morrow, C. Kent Osborne (eds) Dis-eases of the Breast. Lippincott Williams & Wilkins, Philidelphia, 2000, pp 383–401

    Google Scholar 

  31. Buerger H, Otterbach F, Simon R, Schafer KL, Poremba C, Diallo R, Brinkschmidt C, Dockhorn-Dworniczak B, Boecker W: Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morpho-logical subtypes. J Pathol 189: 521–526, 1999

    Google Scholar 

  32. Kerlikowske K, Barclay J, Grady D, Sickles EA, Ernster V: Comparison of risk factors for ductal carcinoma in situ and invasive breast cancer. J Natl Cancer Inst 89:76–82, 1997

    Google Scholar 

  33. Evans WP 3rd, Starr AL, Bennos ES: Comparison of the relative incidence of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. Radiology 204: 489–491, 1997

    Google Scholar 

  34. Wazer DE, Gage I, Homer MJ, Krosnick SH, Schmid C: Age-related differences in patients with nonpalpable breast carcinomas. Cancer 78:1432–1437, 1996

    Google Scholar 

  35. Ernster VL, Ballard-Barbash R, Barlow WE, Zheng Y, Weaver DL, Cutter G, Yankaskas BC, Rosenberg R, Carney PA, Kerlikowske K, Taplin SH, Urban N, Geller BM: Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 94:1546–1554, 2002

    Google Scholar 

  36. Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA: Breast cancer and atypia among young and middle-aged women:a study of 110 medicolegal autopsies. Br J Cancer 56:814–819, 1987

    Google Scholar 

  37. Alpers CE, Wellings SR: The prevalence of carcinoma in situ in normal and cancer-associated breasts. Hum Pathol 16:796–807, 1985

    Google Scholar 

  38. Kramer WM, Rush BF,Jr.:Mammary duct proliferation in the elderly. A histopathologic study. Cancer 31:130–137, 1973

    Google Scholar 

  39. Rush BF, Jr., Kramer WM: Proliferative Histologic Changes and Occult Carcinoma in the Breast of the Aging Female. Surg Gynecol Obstet 117:425–432, 1963

    Google Scholar 

  40. Bodian CA: Benign breast diseases, carcinoma in situ, and breast cancer risk. Epidemiol Rev 15:177–187, 1993

    Google Scholar 

  41. Fearon ER, Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61:759–767, 1990

    Google Scholar 

  42. Hellman S: Natural history of small breast cancers. J Clin Oncol 12:2229–2234, 1994

    Google Scholar 

  43. Jordan VC, Costa AF:Chemoprevention. In:Jay R Harris, Marc E Lippman, Monica Morrow, C Kent Osborne (eds) Diseases of the Breast. Lippincott Williams & Wilkins, Philidelphia, 2000,pp 265–279

    Google Scholar 

  44. Boecker W, Buerger H: Evidence of progenitor cells of glandular and myoepithelial cell lineages in the human adult female breast epithelium:a new progenitor (adult stem)cell concept. Cell Prolif 36 Suppl 1:73–84, 2003

    Google Scholar 

  45. Reis-Filho JS, Lakhani SR:The diagnosis and management of pre-invasive breast disease: Genetic alterations in pre-invasive lesions. Breast Cancer Res 5:313–319, 2003

    Google Scholar 

  46. Shackney SE, Silverman JF:Molecular evolutionary patterns in breast cancer. Adv Anat Pathol 10:278–290, 2003

    Google Scholar 

  47. Page DL:Segregation analysis of breast cancer:histopa-thologic data. J Natl Cancer Inst 83:648,1991

    Google Scholar 

  48. Wingo PA, Ory HW, Layde PM, Lee NC:The evaluation of the data collection process for a multicenter, population-based,case–control design. Am J Epidemiol 128:206–217, 1988

    Google Scholar 

  49. Morabia A, Flandre P:Misclassi cation bias related to de nition of menopausal status in case-control studies of breast cancer. Int J Epidemiol 21:222–228, 1992

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. DHHS/NIH/NCI/Division of Cancer Prevention, EPN, Suite 2141, 6130 Executive Boulevard, Bethesda, MD, 20892, USA

    William F. Anderson

  2. DHHS/NIH/NCI/Center to Reduce Cancer Health Disparities, USA

    Kenneth C. Chu

  3. NCI/Division of Cancer Epidemiology and Genetics, Bethesda, MD, USA

    Susan S. Devesa

Authors
  1. William F. Anderson
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kenneth C. Chu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Susan S. Devesa
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anderson, W.F., Chu, K.C. & Devesa, S.S. Distinct incidence patterns among in situ and invasive breast carcinomas,with possible etiologic implications. Breast Cancer Res Treat 88, 149–159 (2004). https://doi.org/10.1007/s10549-004-1483-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-004-1483-9

Search

Navigation